Furthermore, AT insulin resistance in muscle tissue plays a key role in the development of metabolic and histological abnormalities in obese patients with non-alcoholic fatty liver disease (NAFLD) [36]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.